Quick Takeaways
- This page summarizes Amy DuRoss's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 17 Dec 2025, 17:25.
Amy DuRoss - 15 Dec 2025 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Role
- Director
- Signature
- /s/ Amy DuRoss
- Issuer symbol
- BLFS
- Transactions as of
- 15 Dec 2025
- Net transactions value
- -$49,200
- Form type
- 4
- Filing time
- 17 Dec 2025, 17:25:59 UTC
- Previous filing
- 28 Nov 2025
- Next filing
- 26 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Amy DuRoss filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 17 Dec 2025."
What Changed
- Previous filing in this sequence was filed on 28 Nov 2025.
- Current net transaction value: -$49,200.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DuRoss Amy | Director | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL | /s/ Amy DuRoss | 17 Dec 2025 | 0001854968 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLFS | Common Stock | Sale | $49,200 | -2,000 | -9.7% | $24.60 | 18,687 | 15 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.